{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:08:01Z","timestamp":1785812881435,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,22]],"date-time":"2010-06-22T00:00:00Z","timestamp":1277164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2377-10-51","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T09:34:30Z","timestamp":1282728870000},"source":"Crossref","is-referenced-by-count":49,"title":["Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism"],"prefix":"10.1186","volume":"10","author":[{"given":"Niklas","family":"Mattsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bremell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Anckars\u00e4ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Anckars\u00e4ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,22]]},"reference":[{"issue":"9533","key":"332_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. Lancet. 2006, 368 (9533): 387-403. 10.1016\/S0140-6736(06)69113-7.","journal-title":"Lancet"},{"issue":"8","key":"332_CR2","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L, et al: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol. 2008, 65 (8): 1102-1107. 10.1001\/archneur.65.8.1102.","journal-title":"Arch Neurol"},{"issue":"4","key":"332_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/1352458508100031","volume":"15","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Axelsson M, Haghighi S, Malmestrom C, Wu G, Anckarsater R, Sankaranarayanan S, Andreasson U, Fredrikson S, Gundersen A, et al: Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler. 2009, 15 (4): 448-454. 10.1177\/1352458508100031.","journal-title":"Mult Scler"},{"issue":"1","key":"332_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2377-9-63","volume":"9","author":"M Gisslen","year":"2009","unstructured":"Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, et al: Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol. 2009, 9 (1): 63-10.1186\/1471-2377-9-63.","journal-title":"BMC Neurol"},{"issue":"6","key":"332_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S1474-4422(07)70128-X","volume":"6","author":"AR Pachner","year":"2007","unstructured":"Pachner AR, Steiner I: Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol. 2007, 6 (6): 544-552. 10.1016\/S1474-4422(07)70128-X.","journal-title":"Lancet Neurol"},{"issue":"9","key":"332_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJM198908313210906","volume":"321","author":"AC Steere","year":"1989","unstructured":"Steere AC: Lyme disease. N Engl J Med. 1989, 321 (9): 586-596. 10.1056\/NEJM198908313210906.","journal-title":"N Engl J Med"},{"issue":"4","key":"332_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0404.2006.00741.x","volume":"115","author":"R Anckarsater","year":"2007","unstructured":"Anckarsater R, Vasic N, Jideus L, Kristiansson M, Zetterberg H, Blennow K, Anckarsater H: Cerebrospinal fluid protein reactions during non-neurological surgery. Acta Neurol Scand. 2007, 115 (4): 254-259. 10.1111\/j.1600-0404.2006.00741.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"332_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1086\/515145","volume":"28","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L: Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis. 1999, 28 (3): 569-574. 10.1086\/515145.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"332_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02815140","volume":"26","author":"K Blennow","year":"1995","unstructured":"Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E: Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol Chem Neuropathol. 1995, 26 (3): 231-245. 10.1007\/BF02815140.","journal-title":"Mol Chem Neuropathol"},{"issue":"1","key":"332_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(00)01036-3","volume":"285","author":"E Vanmechelen","year":"2000","unstructured":"Vanmechelen E, Vanderstichele H, Davidsson P, Van Kerschaver E, Van Der Perre B, Sjogren M, Andreasen N, Blennow K: Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization. Neurosci Lett. 2000, 285 (1): 49-52. 10.1016\/S0304-3940(00)01036-3.","journal-title":"Neurosci Lett"},{"issue":"5","key":"332_CR11","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","volume":"67","author":"LE Rosengren","year":"1996","unstructured":"Rosengren LE, Karlsson JE, Karlsson JO, Persson LI, Wikkelso C: Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. J Neurochem. 1996, 67 (5): 2013-2018. 10.1046\/j.1471-4159.1996.67052013.x.","journal-title":"J Neurochem"},{"issue":"9","key":"332_CR12","first-page":"1005","volume":"12","author":"T Wyss-Coray","year":"2006","unstructured":"Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat Med. 2006, 12 (9): 1005-1015.","journal-title":"Nat Med"},{"issue":"6","key":"332_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2174\/156720509790147179","volume":"6","author":"JC Schlachetzki","year":"2009","unstructured":"Schlachetzki JC, Hull M: Microglial activation in Alzheimer's disease. Curr Alzheimer Res. 2009, 6 (6): 554-563. 10.2174\/156720509790147179.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"332_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0014-4886(03)00027-X","volume":"183","author":"A Olsson","year":"2003","unstructured":"Olsson A, Hoglund K, Sjogren M, Andreasen N, Minthon L, Lannfelt L, Buerger K, Moller HJ, Hampel H, Davidsson P, et al: Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Exp Neurol. 2003, 183 (1): 74-80. 10.1016\/S0014-4886(03)00027-X.","journal-title":"Exp Neurol"},{"key":"332_CR15","doi-asserted-by":"crossref","unstructured":"Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Burger K, Hampel H, Frolich L, Wolf S, et al: Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry. 15 (2): 138-145. 10.1038\/mp.2008.84.","DOI":"10.1038\/mp.2008.84"},{"issue":"9","key":"332_CR16","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1212\/01.wnl.0000183293.95787.b7","volume":"65","author":"BJ Brew","year":"2005","unstructured":"Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L: CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology. 2005, 65 (9): 1490-1492. 10.1212\/01.wnl.0000183293.95787.b7.","journal-title":"Neurology"},{"issue":"12","key":"332_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0304-3940(01)02285-6","volume":"314","author":"M Sjogren","year":"2001","unstructured":"Sjogren M, Gisslen M, Vanmechelen E, Blennow K: Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett. 2001, 314 (12): 33-36. 10.1016\/S0304-3940(01)02285-6.","journal-title":"Neurosci Lett"},{"issue":"6","key":"332_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K: Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999, 56 (6): 673-680. 10.1001\/archneur.56.6.673.","journal-title":"Arch Neurol"},{"issue":"5","key":"332_CR19","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1212\/WNL.54.5.1099","volume":"54","author":"M Otto","year":"2000","unstructured":"Otto M, Esselmann H, Schulz-Shaeffer W, Neumann M, Schroter A, Ratzka P, Cepek L, Zerr I, Steinacker P, Windl O, et al: Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurology. 2000, 54 (5): 1099-1102.","journal-title":"Neurology"},{"issue":"1","key":"332_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1096-9896(200105)194:1<1::AID-PATH871>3.0.CO;2-M","volume":"194","author":"RO Weller","year":"2001","unstructured":"Weller RO: How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?. J Pathol. 2001, 194 (1): 1-3. 10.1002\/1096-9896(200105)194:1<1::AID-PATH871>3.0.CO;2-M.","journal-title":"J Pathol"},{"issue":"1","key":"332_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.brainres.2006.10.074","volume":"1131","author":"M Sanchez-Alavez","year":"2007","unstructured":"Sanchez-Alavez M, Chan SL, Mattson MP, Criado JR: Electrophysiological and cerebrovascular effects of the alpha-secretase-derived form of amyloid precursor protein in young and middle-aged rats. Brain Res. 2007, 1131 (1): 112-117. 10.1016\/j.brainres.2006.10.074.","journal-title":"Brain Res"},{"issue":"7232","key":"332_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/nature07767","volume":"457","author":"A Nikolaev","year":"2009","unstructured":"Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature. 2009, 457 (7232): 981-989. 10.1038\/nature07767.","journal-title":"Nature"},{"issue":"2","key":"332_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1468-1331.1999.tb00010.x","volume":"6","author":"L Dotevall","year":"1999","unstructured":"Dotevall L, Hagberg L, Karlsson JE, Rosengren LE: Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis. Eur J Neurol. 1999, 6 (2): 169-178. 10.1111\/j.1468-1331.1999.tb00010.x.","journal-title":"Eur J Neurol"},{"issue":"8","key":"332_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1473-3099(03)00722-9","volume":"3","author":"UR Hengge","year":"2003","unstructured":"Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T: Lyme borreliosis. Lancet Infect Dis. 2003, 3 (8): 489-500. 10.1016\/S1473-3099(03)00722-9.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"332_CR25","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s004150070134","volume":"247","author":"M Studahl","year":"2000","unstructured":"Studahl M, Rosengren L, Gunther G, Hagberg L: Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction. J Neurol. 2000, 247 (8): 636-642. 10.1007\/s004150070134.","journal-title":"J Neurol"},{"issue":"2","key":"332_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/37.2.2492045","volume":"37","author":"JQ Trojanowski","year":"1989","unstructured":"Trojanowski JQ, Schuck T, Schmidt ML, Lee VM: Distribution of tau proteins in the normal human central and peripheral nervous system. J Histochem Cytochem. 1989, 37 (2): 209-215.","journal-title":"J Histochem Cytochem"},{"issue":"10","key":"332_CR27","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/clinchem\/47.10.1776","volume":"47","author":"M Sjogren","year":"2001","unstructured":"Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, et al: Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem. 2001, 47 (10): 1776-1781.","journal-title":"Clin Chem"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-10-51.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-10-51\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-10-51","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T22:27:23Z","timestamp":1591828043000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-10-51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,22]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-10-51","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,22]]},"article-number":"51"}}